Dordaviprone Hydrochloride Patent Expiration
Dordaviprone Hydrochloride was first introduced by Chimerix Inc
Dordaviprone Hydrochloride Patents
Given below is the list of patents protecting Dordaviprone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Modeyso | US10172862 | Jan 30, 2037 | Chimerix | |
| Modeyso | US10369154 | Jan 30, 2037 | Chimerix | |
| Modeyso | US12102639 | Jan 30, 2037 | Chimerix | |
| Modeyso | US11976068 | Mar 01, 2036 | Chimerix | |
| Modeyso | US9265765 | Jul 26, 2034 | Chimerix | |
| Modeyso | US9629842 | Apr 30, 2032 | Chimerix | |
| Modeyso | USRE46290 | Apr 30, 2032 | Chimerix |
Dordaviprone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List